KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Long-Term Deferred Tax (2016 - 2025)

Teva Pharmaceutical Industries' Long-Term Deferred Tax history spans 12 years, with the latest figure at $2.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 21.79% year-over-year to $2.2 billion, compared with a TTM value of $2.2 billion through Dec 2025, up 21.79%, and an annual FY2025 reading of $2.2 billion, up 21.79% over the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $2.2 billion at Teva Pharmaceutical Industries, up from $1.6 billion in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $2.2 billion in Q4 2025, with the low at $596.0 million in Q4 2021.
  • Average Long-Term Deferred Tax over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2022.
  • Year-over-year, Long-Term Deferred Tax skyrocketed 148.55% in 2022 and then decreased 21.06% in 2025.
  • Tracing TEVA's Long-Term Deferred Tax over 5 years: stood at $596.0 million in 2021, then soared by 144.63% to $1.5 billion in 2022, then increased by 24.28% to $1.8 billion in 2023, then fell by 0.72% to $1.8 billion in 2024, then increased by 21.79% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Long-Term Deferred Tax are $2.2 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.8 billion (Q2 2025).